Lykis Ltd
- Market Cap ₹ 69.9 Cr.
- Current Price ₹ 36.1
- High / Low ₹ 60.0 / 25.3
- Stock P/E 22.0
- Book Value ₹ 17.6
- Dividend Yield 0.00 %
- ROCE 10.0 %
- ROE 9.70 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.8%
- Debtor days have improved from 76.4 to 41.8 days.
- Company's working capital requirements have reduced from 98.8 days to 72.2 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Earnings include an other income of Rs.3.26 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
129 | 168 | 107 | 107 | 148 | 147 | 84 | 63 | 329 | 454 | 404 | 297 | |
130 | 166 | 104 | 110 | 149 | 145 | 85 | 71 | 329 | 429 | 395 | 290 | |
Operating Profit | -1 | 2 | 2 | -3 | -1 | 2 | -1 | -8 | 0 | 25 | 10 | 7 |
OPM % | -1% | 1% | 2% | -3% | -1% | 2% | -1% | -12% | 0% | 6% | 2% | 2% |
2 | 1 | 1 | 3 | 3 | -1 | 2 | 1 | 6 | 3 | 3 | 3 | |
Interest | 1 | 2 | 2 | 3 | 5 | 2 | 3 | 2 | 3 | 7 | 8 | 6 |
Depreciation | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 1 | 2 |
Profit before tax | -1 | 0 | 1 | -3 | -4 | -2 | -2 | -9 | 2 | 20 | 4 | 3 |
Tax % | 55% | 76% | 64% | 4% | -3% | 45% | 0% | -28% | -7% | 19% | -5% | 23% |
-1 | 0 | 0 | -3 | -4 | -2 | -2 | -7 | 2 | 16 | 4 | 3 | |
EPS in Rs | -1.02 | 0.06 | 0.18 | -1.78 | -1.85 | -1.25 | -0.98 | -3.47 | 1.25 | 8.12 | 2.00 | 1.35 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 29% |
3 Years: | -3% |
TTM: | -26% |
Compounded Profit Growth | |
---|---|
10 Years: | 29% |
5 Years: | 30% |
3 Years: | 10% |
TTM: | -18% |
Stock Price CAGR | |
---|---|
10 Years: | -7% |
5 Years: | 15% |
3 Years: | 12% |
1 Year: | -28% |
Return on Equity | |
---|---|
10 Years: | 4% |
5 Years: | 18% |
3 Years: | 28% |
Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 19 | 19 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
Reserves | 5 | 5 | 8 | 3 | -3 | -2 | -4 | -10 | -8 | 8 | 12 | 14 |
45 | 62 | 52 | 86 | 113 | 43 | 49 | 51 | 113 | 144 | 89 | 43 | |
12 | 17 | 24 | 10 | 44 | 36 | 10 | 27 | 11 | 13 | 21 | 14 | |
Total Liabilities | 82 | 102 | 104 | 119 | 174 | 98 | 76 | 88 | 135 | 185 | 141 | 91 |
12 | 11 | 13 | 13 | 14 | 13 | 15 | 3 | 4 | 5 | 5 | 3 | |
CWIP | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Investments | 10 | 5 | 12 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
59 | 84 | 79 | 105 | 159 | 83 | 59 | 85 | 130 | 179 | 136 | 88 | |
Total Assets | 82 | 102 | 104 | 119 | 174 | 98 | 76 | 88 | 135 | 185 | 141 | 91 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-29 | -22 | 15 | -33 | 2 | 36 | 9 | -22 | -64 | -23 | 66 | 57 | |
-11 | 4 | -8 | 9 | 0 | 2 | -0 | 9 | 10 | -0 | -1 | -5 | |
44 | 16 | -6 | 33 | 23 | -68 | -8 | 13 | 58 | 21 | -63 | -51 | |
Net Cash Flow | 5 | -2 | 2 | 10 | 25 | -30 | 1 | 0 | 3 | -3 | 3 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 60 | 96 | 75 | 107 | 74 | 49 | 40 | 114 | 67 | 100 | 87 | 42 |
Inventory Days | 9 | 8 | 20 | 19 | 23 | 14 | 4 | 80 | 17 | 15 | 10 | 22 |
Days Payable | 31 | 32 | 10 | 20 | 18 | 45 | 22 | 56 | 11 | 8 | 12 | 14 |
Cash Conversion Cycle | 38 | 72 | 85 | 105 | 79 | 18 | 22 | 138 | 73 | 106 | 86 | 50 |
Working Capital Days | 110 | 135 | 162 | 263 | 168 | 87 | 112 | 243 | 122 | 129 | 95 | 72 |
ROCE % | 1% | 2% | 4% | -0% | 1% | 3% | 1% | -12% | 6% | 18% | 8% | 10% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Jul - Certificate confirming no shares dematerialized in Q1 FY2025-26 under SEBI regulation 74(5).
-
Change In Name Of Subsidiary Company.
3 Jul - Subsidiary renamed from Lykis Marketing Pvt Ltd to Goldspan Exports Pvt Ltd effective July 3, 2025.
-
Closure of Trading Window
25 Jun - Trading window closed from July 1 till 48 hours post Q1 2025 results declaration.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations') - Cessation Of Lykis Biscuits Private Limited And Lykis Packaging Private Limited As An Associate Company Of The Lykis Limited.
11 Jun - Lykis Limited exits two loss-making associates, selling shares to independent buyer on June 11, 2025.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
26 May - Lykis Limited's Annual Secretarial Compliance Report for FY ended March 31, 2025; no non-compliance noted.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
Company offers manufacturing support for private labelling in domestic and 40+ countries